Comparative study to evaluate dosimetric differences in patients of locally advanced carcinoma cervix undergoing intracavitary brachytherapy under two different anaesthesia techniques: an audit from a tertiary cancer centre in India

Journal of the Egyptian National Cancer Institute

Table 3 EQD2 dose received by 2 cc OARs

Organs at risk	Group	N	Mean	Std. deviation	Min	Max	p value	95% CI of the difference
Organs at risk	Group	N	Mean	Std. deviation	Min	Max	p value	Lower	Upper
Sigmoid Colon	GA	16	62.2031	8.33009	49.68	77.05	.789	− 6.04624	4.62828
Sigmoid Colon	PS	19	62.9121	7.19461	50.99	79.74	.789	− 6.04624	4.62828
Bladder	GA	16	79.5156	10.70180	51.18	95.62	.677	− 5.94628	9.03964
Bladder	PS	19	77.9689	10.97947	56.64	96.24	.677	− 5.94628	9.03964
Rectum	GA	16	63.4744	5.78111	54.86	77.48	.024*	− 11.27340	− .86417
Rectum	PS	19	69.5432	8.73826	54.21	90.95	.024*	− 11.27340	− .86417